Home Transgene

Transgene

acquired
Post-IPO Round
Comprehensive Biopharmaceutical Company

Basic Information

Transgene is a fully integrated biopharmaceutical company focused on designing and developing cutting-edge immunotherapy products for the treatment of cancer and chronic infectious diseases. Their expertise spans all stages of product development, from research to clinical-scale manufacturing and conducting clinical trials.
Transgene SA
Strasbourg,GreatEast,France
more than 500 people
January 01, 1979
communication@transgene.fr